A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections. [electronic resource]
- Journal of virology Jun 2012
- 6563-74 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't